Clinical Trial Update: High Altitude Residents With High Altitude Pulmonary Hypertension (HAPH), 6MWT Assessed at High Altitude (3200m) vs Low Altitude (760m) [NA]

View source ↗

Summary

A completed clinical trial evaluating the 6-minute walk test in individuals with high altitude pulmonary hypertension at high altitude (3200 m) versus low altit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High Altitude Pulmonary Hypertension

Snippet

Sponsor: University of Zurich | Conditions: High Altitude Pulmonary Hypertension | NA | Status: COMPLETED